Functional Neuromodulation
PrivateLast Round
VC Round
Jan 15, 2021
Total Funding Raised
$19.5M
Company Overview
Functional Neuromodulation is a healthcare technology company that develops deep brain stimulation technologies aimed at treating Alzheimer's disease through surgically implanted devices that deliver electrical pulses to the fornix.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Functional Neuromodulation Comparables
Compare Functional Neuromodulation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Braingrade | 83% | |
| Aleva Neurotherapeutics | 77% | |
| Medtronic | 75% |
Functional Neuromodulation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 15, 2021 | ||||
| Grant | Aug 7, 2012 | ||||
| Grant | Jun 1, 2012 | ||||
| Series B | Mar 13, 2012 | ||||
| Series A | Oct 17, 2011 | ||||
Seed | Nov 11, 2010 |
Functional Neuromodulation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Aging | Grant |
| Genesys Capital | VC Round, Series B, Series A, Seed |
| National Institute on Aging | Grant |
| Medtronic | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 7, 2012
Secured $2.75M from the National Institute on Aging.
- Jun 1, 2012
$2.75M grant from the National Institute on Aging.
Functional Neuromodulation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Functional Neuromodulation's valuation, stock price, and market status.
Is Functional Neuromodulation a public or private company?
Functional Neuromodulation is a private company.
What is the current stock price of Functional Neuromodulation?
Functional Neuromodulation is a private company, so its shares have no public market price. Caplight tracks Functional Neuromodulation's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Functional Neuromodulation worth (valuation)?
Valuation information for Functional Neuromodulation is not publicly available.
Can I buy Functional Neuromodulation stock?
Functional Neuromodulation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Functional Neuromodulation's last funding round?
Functional Neuromodulation's most recent funding round was VC Round on January 15, 2021.
Who are the main investors in Functional Neuromodulation?
Key investors in Functional Neuromodulation include Genesys Capital.
Will Functional Neuromodulation IPO soon?
No public IPO plans have been announced for Functional Neuromodulation.
How can I track Functional Neuromodulation secondary market activity?
Caplight tracks bids, offers, and trades in Functional Neuromodulation's shares on secondary markets.